Cell and Tissue Research

, Volume 360, Issue 2, pp 309–319 | Cite as

Oncostatin M regulates osteogenic differentiation of murine adipose-derived mesenchymal progenitor cells through a PKCdelta-dependent mechanism

  • David C. Smyth
  • Shunsuke Takenaka
  • Celine Yeung
  • Carl D. RichardsEmail author
Regular Article


Oncostatin M (OSM) is an IL-6/LIF family cytokine that influences mesenchymal progenitor differentiation; however, the mechanisms of this activity have not been fully elucidated. Using uncommitted murine adipose tissue-derived mesenchymal progenitors, we have examined mechanisms of OSM-induced osteogenesis. Murine OSM (mOSM) induced osteogenic differentiation to a greater degree than interleukin (IL)-6 and other members of the gp130 cytokine family, promoting extracellular matrix mineralization as indicated by Alizarin Red S staining. mOSM also increased expression of osteogenesis-associated gene products BMP4, BMP7, Runx-2, and osteocalcin as assessed by immunoblotting and real-time quantitative PCR. Additionally, protein kinase C (PKC) delta activity was upregulated in response to OSM stimulation, and to a greater degree than IL-6. Knockdown of PKCdelta expression by use of RNA interference (RNAi) reduced OSM-mediated osteogenic differentiation and decreased expression of Runx-2. These findings suggest that OSM differentially promotes osteogenesis in non-committed mesenchymal progenitors relative to other gp130 cytokines. This activity correlates with selective activation of PKCdelta in OSM-treated cells, indicating that OSM-induced osteogenesis and upregulation of osteogenic gene products require activity of PKCdelta.


Osteogenesis Signal transduction Gene regulation Cytokines Oncostatin M 



The authors want to thank Christine Demers, Carrie M. Langdon, and Rebecca Rodrigues (McMaster University) for excellent technical assistance, and Steven Wong (McMaster University) for review of the manuscript. This work was supported by CIHR grant # 102565.

Conflict of Interest

None declared.


  1. Albasanz-Puig A, Murray J, Preusch M et al (2011) Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis. Atherosclerosis 216:292–298. doi: 10.1016/j.atherosclerosis.2011.02.003 CrossRefPubMedGoogle Scholar
  2. Bamber B, Reife RA, Haugen HS, Clegg CH (1998) Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease. J Mol Med (Berl) 76:61–69CrossRefGoogle Scholar
  3. Bellido T, Stahl N, Farruggella TJ et al (1996) Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 97:431–437. doi: 10.1172/JCI118432 CrossRefPubMedCentralPubMedGoogle Scholar
  4. Cawston TE, Curry VA, Summers CA et al (1998) The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 41:1760–1771. doi: 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M CrossRefPubMedGoogle Scholar
  5. Chattopadhyay S, Tracy E, Liang P et al (2007) Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J Biol Chem 282:3014–3026. doi: 10.1074/jbc.M609655200 CrossRefPubMedGoogle Scholar
  6. Chipoy C, Berreur M, Couillaud S et al (2004) Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. J Bone Miner Res 19:1850–1861. doi: 10.1359/JBMR.040817 CrossRefPubMedGoogle Scholar
  7. De Bari C, Dell’Accio F, Tylzanowski P, Luyten FP (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928–1942. doi: 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P CrossRefPubMedGoogle Scholar
  8. Dennis JE, Merriam A, Awadallah A et al (1999) A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 14:700–709. doi: 10.1359/jbmr.1999.14.5.700 CrossRefPubMedGoogle Scholar
  9. Ducy P, Zhang R, Geoffroy V et al (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747–754CrossRefPubMedGoogle Scholar
  10. Duncan MR, Hasan A, Berman B (1995) Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J Invest Dermatol 104:128–133CrossRefPubMedGoogle Scholar
  11. Falconi D, Aubin JE (2007) LIF inhibits osteoblast differentiation at least in part by regulation of HAS2 and its product hyaluronan. J Bone Miner Res 22:1289–1300. doi: 10.1359/jbmr.070417 CrossRefPubMedGoogle Scholar
  12. Fan J, Guan S, Cheng C-F et al (2006) PKCdelta clustering at the leading edge and mediating growth factor-enhanced, but not ecm-initiated, dermal fibroblast migration. J Invest Dermatol 126:1233–1243. doi: 10.1038/sj.jid.5700149 CrossRefPubMedGoogle Scholar
  13. Franchimont N, Wertz S, Malaise M (2005) Interleukin-6: An osteotropic factor influencing bone formation? Bone 37:601–606. doi: 10.1016/j.bone.2005.06.002 CrossRefPubMedGoogle Scholar
  14. Grenier A, Combaux D, Chastre J et al (2001) Oncostatin M production by blood and alveolar neutrophils during acute lung injury. Lab Invest 81:133–141CrossRefPubMedGoogle Scholar
  15. Gschwendt M (1999) Protein kinase C delta. Eur J Biochem 259:555–564CrossRefPubMedGoogle Scholar
  16. Guihard P, Danger Y, Brounais B et al (2012) Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 30:762–772. doi: 10.1002/stem.1040 CrossRefPubMedGoogle Scholar
  17. Hui W, Bell M, Carroll G (1997) Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 56:184–187CrossRefPubMedCentralPubMedGoogle Scholar
  18. Jaiswal RK, Jaiswal N, Bruder SP et al (2000) Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645–9652CrossRefPubMedGoogle Scholar
  19. Jay PR, Centrella M, Lorenzo J et al (1996) Oncostatin-M: a new bone active cytokine that activates osteoblasts and inhibits bone resorption. Endocrinology 137:1151–1158. doi: 10.1210/endo.137.4.8625883 PubMedGoogle Scholar
  20. Jimenez SA, Gaidarova S, Saitta B et al (2001) Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 108:1395–1403. doi: 10.1172/JCI12347 CrossRefPubMedCentralPubMedGoogle Scholar
  21. Kang HJ, Kang JS, Lee SH et al (2005) Upregulation of oncostatin m in allergic rhinitis. Laryngoscope 115:2213–2216. doi: 10.1097/01.mlg.0000187819.89889.4a CrossRefPubMedGoogle Scholar
  22. Kerr C, Langdon C, Graham F et al (1999) Adenovirus vector expressing mouse oncostatin M induces acute-phase proteins and TIMP-1 expression in vivo in mice. J Interferon Cytokine Res 19:1195–1205. doi: 10.1089/107999099313145 CrossRefPubMedGoogle Scholar
  23. Koch H, Jadlowiec JA, Campbell PG (2005) Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14:621–631. doi: 10.1089/scd.2005.14.621 CrossRefPubMedGoogle Scholar
  24. Kruger JS, Reddy KB (2003) Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Mol Cancer Res 1:801–809PubMedGoogle Scholar
  25. Langdon C, Kerr C, Tong L, Richards CD (2003) Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. J Immunol 170:548–555CrossRefPubMedGoogle Scholar
  26. Li WQ, Dehnade F, Zafarullah M (2001) Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 166:3491–3498CrossRefPubMedGoogle Scholar
  27. Li W, Nadelman C, Gratch NS et al (2002) An important role for protein kinase C-delta in human keratinocyte migration on dermal collagen. Exp Cell Res 273:219–228. doi: 10.1006/excr.2001.5422 CrossRefPubMedGoogle Scholar
  28. Luzina IG, Atamas SP, Wise R et al (2003) Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum 48:2262–2274. doi: 10.1002/art.11080 CrossRefPubMedGoogle Scholar
  29. Malaval L, Liu F, Vernallis AB, Aubin JE (2005) GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. J Cell Physiol 204:585–593. doi: 10.1002/jcp.20312 CrossRefPubMedGoogle Scholar
  30. Malik N, Haugen HS, Modrell B et al (1995) Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol 15:2349–2358PubMedCentralPubMedGoogle Scholar
  31. Mishra R, Zhu L, Eckert RL, Simonson MS (2007) TGF-beta-regulated collagen type I accumulation: role of Src-based signals. Am J Physiol Cell Physiol 292:C1361–C1369. doi: 10.1152/ajpcell.00370.2006 CrossRefPubMedGoogle Scholar
  32. Miyaoka Y, Tanaka M, Naiki T, Miyajima A (2006) Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J Biol Chem 281:37913–37920. doi: 10.1074/jbc.M606089200 CrossRefPubMedGoogle Scholar
  33. Modur V, Feldhaus MJ, Weyrich AS et al (1997) Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 100:158–168. doi: 10.1172/JCI119508 CrossRefPubMedCentralPubMedGoogle Scholar
  34. Nakamura Y, Tensho K, Nakaya H et al (2005) Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36:399–407. doi: 10.1016/j.bone.2004.11.010 CrossRefPubMedGoogle Scholar
  35. O’Hara KA, Kedda M-A, Thompson PJ, Knight DA (2003) Oncostatin M: an interleukin-6-like cytokine relevant to airway remodelling and the pathogenesis of asthma. Clin Exp Allergy 33:1026–1032CrossRefPubMedGoogle Scholar
  36. Okamoto H, Yamamura M, Morita Y et al (1997) The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 40:1096–1105. doi: 10.1002/1529-0131(199706)40:6<1096::AID-ART13>3.0.CO;2-D CrossRefPubMedGoogle Scholar
  37. Otto F, Thornell AP, Crompton T et al (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765–771CrossRefPubMedGoogle Scholar
  38. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147CrossRefPubMedGoogle Scholar
  39. Quach JM, Walker EC, Allan E et al (2011) Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment. J Biol Chem 286:4186–4198. doi: 10.1074/jbc.M110.178251 CrossRefPubMedCentralPubMedGoogle Scholar
  40. Rickard DJ, Sullivan TA, Shenker BJ et al (1994) Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218–228. doi: 10.1006/dbio.1994.1022 CrossRefPubMedGoogle Scholar
  41. Rodriguez A-M, Pisani D, Dechesne CA et al (2005) Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201:1397–1405. doi: 10.1084/jem.20042224 CrossRefPubMedCentralPubMedGoogle Scholar
  42. Schindeler A, Little DG (2006) Ras-MAPK signaling in osteogenic differentiation: friend or foe? J Bone Miner Res 21:1331–1338. doi: 10.1359/jbmr.060603 CrossRefPubMedGoogle Scholar
  43. Schnittker D, Kwofie K, Ashkar A et al (2013) Oncostatin M and TLR-4 ligand synergize to induce MCP-1, IL-6, and VEGF in human aortic adventitial fibroblasts and smooth muscle cells. Mediators Inflamm 2013:317503. doi: 10.1155/2013/317503 CrossRefPubMedCentralPubMedGoogle Scholar
  44. Sekiya I, Larson BL, Smith JR et al (2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20:530–541. doi: 10.1634/stemcells.20-6-530 CrossRefPubMedGoogle Scholar
  45. Smyth DC, Kerr C, Richards CD (2006) Oncostatin M-induced IL-6 expression in murine fibroblasts requires the activation of protein kinase Cdelta. J Immunol 177:8740–8747CrossRefPubMedGoogle Scholar
  46. Song HY, Jeon ES, Kim JI et al (2007) Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 101:1238–1251. doi: 10.1002/jcb.21245 CrossRefPubMedGoogle Scholar
  47. Suga K, Saitoh M, Kokubo S et al (2003) Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model. J Interferon Cytokine Res 23:203–207. doi: 10.1089/107999003765027401 CrossRefPubMedGoogle Scholar
  48. Tanaka M, Hirabayashi Y, Sekiguchi T et al (2003) Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood 102:3154–3162. doi: 10.1182/blood-2003-02-0367 CrossRefPubMedGoogle Scholar
  49. Walker EC, McGregor NE, Poulton IJ et al (2008) Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J Bone Miner Res 23:2025–2032. doi: 10.1359/jbmr.080706 CrossRefPubMedGoogle Scholar
  50. Walker EC, McGregor NE, Poulton IJ et al (2010) Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest 120:582–592. doi: 10.1172/JCI40568 CrossRefPubMedCentralPubMedGoogle Scholar
  51. Walker EC, Poulton IJ, McGregor NE et al (2012) Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. J Bone Miner Res 27:902–912. doi: 10.1002/jbmr.1506 CrossRefPubMedGoogle Scholar
  52. Wong S, Botelho FM, Rodrigues RM, Richards CD (2014) Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 Dysregulation in lungs of fibrosis-resistant BALB/c mice. Lab Invest. doi: 10.1038/labinvest.2014.81 PubMedGoogle Scholar
  53. Zuk PA, Zhu M, Ashjian P et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295. doi: 10.1091/mbc.E02-02-0105 CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • David C. Smyth
    • 1
  • Shunsuke Takenaka
    • 2
  • Celine Yeung
    • 2
  • Carl D. Richards
    • 2
    • 3
    Email author
  1. 1.Currently at University of Ottawa Heart InstituteUniversity of OttawaOttawaCanada
  2. 2.McMaster Immunology Research Centre, Department of Pathology and Molecular MedicineMcMaster UniversityHamiltonCanada
  3. 3.MDCL-4017, Department of Pathology and Molecular MedicineMcMaster UniversityHamiltonCanada

Personalised recommendations